Acarix strengthens US sales leadership team
Acarix, a leader in advanced acoustic-based cardiac diagnostics, announces a new US sales structure that aims to further strengthen its...
Acarix changes Certified Adviser to Carnegie Investment Bank AB (publ)
Acarix, a leader in advanced acoustic-based cardiac diagnostics, today announces a change of Certified Adviser from Erik Penser Bank AB...
Southeast Louisiana VA Healthcare System Reorders CADScor Patches
Acarix, a leader in advanced acoustic-based cardiac diagnostics, today announces an advancement in the utilization of its CADScor® ...
ACARIX CARRIES OUT A DIRECTED ISSUE TO GUARANTORS FOLLOWING THE COMPLETED RIGHTS ISSUE
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG ...
Acarix AB (publ) publishes Interim Report, July – September 2023
Continued momentum in the US and strengthened financing in placeWe are pleased with the Q3 revenue growth in the US, where we are makin...
Invitation to presentation of Acarix´s third quarter report
Acarix will publish its third quarter results on Thursday 9 November 2023 at 08.00 am (CEST). A live webcast will be held at 14.00 (CES...
Last day of trading in paid subscribed units in Acarix’ unit rights issue is 9 November 2023
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Acarix announces final outcome in the rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Acarix announces preliminary outcome of the Rights Issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Invitation to digital live presentation with Acarix
Acarix, a leader in acoustic and AI-based cardiac diagnostics, invites to a digital investor presentation on Friday October 13, 2023 at...
Acarix publishes prospectus in connection with the company’s fully guaranteed rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Acarix appoints industry veteran Fred Colen as acting CEO during temporary medical leave of CEO Helen Ljungdahl Round
Acarix, a leader in acoustic and AI-based cardiac diagnostics, announces that CEO Helen Ljungdahl Round will be taking a temporary medi...